Project Details
Description
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Optune? (TTFields, 200 kHz) Concomitant with Maintenance Temozolomide and Pembrolizumab Versus Optune...
| Status | Active |
|---|---|
| Effective start/end date | 9/9/24 → 9/8/35 |
Funding
- NOVOCURE INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.